Abstract
The supposed superiority of randomized over non-randomized studies is used to justify claims about therapeutic effectiveness of medical interventions and also inclusion criteria for many systematic reviews of therapeutic interventions. However, the view that randomized trials provide better evidence has been challenged by philosophers of science. In addition, empirical evidence for average differences between randomized trials and observational studies (which we would expect if one method were superior) has proven difficult to find. This chapter reviews the controversy surrounding the relative merits of randomized trials and observational studies. It is concluded that while (well-conducted) observational can often provide the same level of evidential support as randomized trials, merits of (well-conducted) randomized trials warrant claims about their superiority, especially where results from the two methods are contradictory.
References
Adler UC, Krüger S, Teut M et al (2013) Homeopathy for depression: a randomized, partially double-blind, placebo-controlled, four-armed study (DEP-HOM). PLoS One 8:e74537
Altman DG (2002) Poor-quality medical research: what can journals do? JAMA J Am Med Assoc 287:2765–2767
Anglemyer A, Horvath HT, Bero L (2014) Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst Rev 4:MR000034
Barbui C, Cipriani A (2007) Publication bias in systematic reviews. Arch Gen Psychiatry 64:868
Berkson J, Magath T, Hurn M (1939) The error of estimate of the blood cell count as made with the hemocytometer. Am J Physiol 128:309–323
Borgerson K (2009) Valuing evidence: bias and the evidence hierarchy of evidence-based medicine. Perspect Biol Med 52:218–233
Boswell K, Cook C, Burch S, Eaddy M, Cantrell R (2012) Associating medication adherence with improved outcomes: a systematic literature review. Am J Pharm Benefits 4:e97–e108
Broadbent A (2013) Jeremy Howick: the philosophy of evidence-based medicine. Philos Sci 80:165–168
Bylund DB, Reed AL (2007) Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs? Neurochem Int 51:246–253
Carlson MD, Morrison RS (2009) Study design, precision, and validity in observational studies. J Palliat Med 12:77–82
Cartwright N (2007) Are RCTs the gold standard? Biosocieties 2:11–20
Cocco G (2009) Erectile dysfunction after therapy with metoprolol: the Hawthorne effect. Cardiology 112:174–177
Coronary Drug Project (1980) Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 303:1038–1041
DeCensi A, Puntoni M, Goodwin P et al (2010) Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res 3:1451–1461
Deupree JD, Reed AL, Bylund DB (2007) Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats. J Pharmacol Exp Ther 321:770–776
Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J (2001) Influence of context effects on health outcomes: a systematic review. Lancet 357:757–762
Eisenach JC, Lindner MD (2004) Did experimenter bias conceal the efficacy of spinal opioids in previous studies with the spinal nerve ligation model of neuropathic pain? Anesthesiology 100:765–767
Every-Palmer S, Howick J (2014) How evidence-based medicine is failing due to biased trials and selective publication. J Eval Clin Pract 20:908–914
Glasziou P, Chalmers I, Rawlings M, McCulloch P (2007) When are randomised trials unnecessary? Picking signal from noise. Br Med J 334:349
Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 22:397–402
Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J 336:924–926
Higgins JJ, Green S (2008) The Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. Wiley Blackwell, Chichester
Howick J (2011) The philosophy of evidence-based medicine. Wiley Blackwell/BMJ Books, Chichester
Howick J, Mebius A (2014). In search of justification for the unpredictability paradox. Trials 15:480
Jefferson T, Demichell V, Di Pietrantonj C, Jones M, Rivetti D (2006). Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 19(3)
Jadad A (1998) Randomized controlled trials. BMJ Books, London
Jefferson T, Jones MA, Doshi P et al (2014) Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 4:CD008965
Jones B, Howick J, Hopewell J, Liew SM (2014) Response to ‘Position statement on ethics, equipoise and research on charged particle therapy’. J Med Ethics 40:576–577
Keen HI, Pile K, Hill CL (2005) The prevalence of underpowered randomized clinical trials in rheumatology. J Rheumatol 32:2083–2088
Knekt P, Reunanen A, Jarvinen R et al (1994) Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 139:1180–1189
La Caze A, Djulbegovic B, Senn S (2012) What does randomization achieve? Evid Based Med 17:1–3
Mant D (1999) Can randomised trials inform clinical decisions about individual patients? Lancet 35:743–746
McCarney R, Warner J, Iliffe S et al (2007) The Hawthorne effect: a randomised, controlled trial. BMC Med Res Methodol 7:30
McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR (1994) Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 121:1–5
McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D (2002) Randomised trials in surgery: problems and possible solutions. Br Med J 324:1448–1451
Mebius A (2014) Corroborating evidence-based medicine. J Eval Clin Pract 20:915–920
Muthuri SG, Venkatesan S, Myles PR et al (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2:395–404
Oberai P, Balachandran I, Janardhanan N et al (2013) Homoeopathic management in depressive episodes: a prospective, unicentric, non-comparative, open-label observational study. Indian J Res Homoeopath 7:116–125
OCEBM Levels of Evidence Working Group (2011) The Oxford 2011 levels of evidence. Oxford Centre for Evidence-Based Medicine. Available at: http://www.cebm.net/index.aspx?o=5653. Accessed 17 June 2011
Odgaard-Jensen J, Vist GE, Timmer A et al (2011) Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev 4:MR000012
Penston J (2003) Fact and fiction in medical research: the large-scale randomised trial. The London Press, London
Petitti DB, Perlman JA, Sidney S (1987) Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol 70:289–293
Rosenthal R, Lawson R (1964) A longitudinal study of the effects of experimenter bias on the operant learning of laboratory rats. J Psychiatr Res 69:61–72
Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA J Am Med Assoc 288:321–333
Schulz KF, Grimes DA (2002) Blinding in randomised trials: hiding who got what. Lancet 359:696–700
Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA J Am Med Assoc 273:408–412
Sesso HD, Buring JE, Christen WG et al (2008) Vitamins E and C in the prevention of cardiovascular disease in men: the physicians’ health study II randomized controlled trial. JAMA J Am Med Assoc 300:2123–2133
Sierevelt IN, van Oldenrijk J, Poolman RW (2007) Is statistical significance clinically important? A guide to judge the clinical relevance of study findings. J Long Term Eff Med Implants 17:173–179
Smith GD, Ebrahim S (2002) Data dredging, bias, or confounding. Br Med J 325:1437–1438
Stampfer MJ, Colditz GA (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20:47–63
Stevens RJ, Ali R, Bankhead CR et al (2012) Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia 55:2593–2603
Straus SE, Glasziou P, Richardson WS, Haynes RB (2011) Evidence-based medicine: how to practice and teach EBM, 4th edn. Churchill Livingston, Edinburgh
Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA J Am Med 283:2008–2012
Vist GE, Bryant D, Somerville L, Birminghem T, Oxman AD (2008) Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database Syst Rev 3:MR000009
Wartolowska K, Judge A, Collins G et al (2014) Use of placebo controls in the evaluation of surgery: systematic review. Br Med J 348:g3253
Wood L, Egger M, Gluud LL et al (2008) Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. Br Med J 336:601–605
Worrall J (2002) What evidence in evidence-based medicine? Philos Sci 69:S316–S330
Worrall J (2007) Evidence in medicine. Philos Compass 2:981–1022
Zetin M, Hoepner CT (2007) Relevance of exclusion criteria in antidepressant clinical trials: a replication study. J Clin Psychopharmacol 27:295–301
Ziegler EJ, Fisher CJ Jr, Sprung CL et al (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N Engl J Med 324:429–436
Zimmerman M, Posternak MA, Chelminski I (2002) Symptom severity and exclusion from antidepressant efficacy trials. J Clin Psychopharmacol 22:610–614
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Howick, J., Mebius, A. (2015). Randomized Trials and Observational Studies: The Current Philosophical Controversy. In: Schramme, T., Edwards, S. (eds) Handbook of the Philosophy of Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-8706-2_45-1
Download citation
DOI: https://doi.org/10.1007/978-94-017-8706-2_45-1
Received:
Accepted:
Published:
Publisher Name: Springer, Dordrecht
Online ISBN: 978-94-017-8706-2
eBook Packages: Springer Reference Religion and PhilosophyReference Module Humanities and Social SciencesReference Module Humanities